Edition:
India

Otonomy Inc (OTIC.OQ)

OTIC.OQ on NASDAQ Stock Exchange Global Select Market

4.45USD
1:30am IST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$4.45
Open
$4.40
Day's High
$4.45
Day's Low
$4.30
Volume
26,561
Avg. Vol
51,748
52-wk High
$21.15
52-wk Low
$2.80

Chart for

About

Otonomy, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. The Company's product candidates include OTIPRIO, OTO-104 and OTO-311. OTIPRIO is a single-dose, physician-administered antibacterial, which is used for the treatment... (more)

Overall

Beta: --
Market Cap(Mil.): $104.55
Shares Outstanding(Mil.): 30.30
Dividend: --
Yield (%): --

Financials

BRIEF-Otonomy Qtrly Loss Per Share $0.37

* OTONOMY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

10 May 2018

BRIEF-Otonomy Qtrly Loss Per Share $‍0.62​

* OTONOMY REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

09 Mar 2018

BRIEF-Otonomy Announces FDA Approval Of Otiprio For Acute Otitis Externa

* OTONOMY ANNOUNCES FDA APPROVAL OF OTIPRIO(R) FOR ACUTE OTITIS EXTERNA

02 Mar 2018

BRIEF-Otonomy Sees 2017 Non-Gaap Expenses Totaling $73-$78 Million

* OTONOMY INC - EXPECTS GAAP OPERATING EXPENSES FOR 2017 TO TOTAL IN RANGE OF $95-$100 MILLION

09 Jan 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF75.60 +0.10
Auris Medical Holding AG (EARS.OQ) $0.90 0.00

Earnings vs. Estimates